Back in 'Control': Tivo Data Explained; AVEO Bags $50M
By Randy Osborne
Friday, January 18, 2013
Stock buyers are putting their faith in AVEO Oncology Inc. to the tune of about $50 million in gross proceeds, coming the firm's way through a public offering expected to close later this month.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.